ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,688.31
      -0.37%
      US Tech 100
      19,226.40
      -0.27%
      Dow Jones
      41,922.21
      -0.65%
      Brent Oil
      76.50
      2.53%
      Bitcoin
      60,145.32
      -0.77%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Prelude Therapeutics Inc (PRLD) Quote

      Prelude Therapeutics Inc

      Prelude Therapeutics Inc (PRLD)

      NASDAQ
      1.9299
      -0.0801
      ( -3.99% )
      Updated: 10:41:47
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      1.9299
      Bid
      1.92
      Ask
      1.93
      Volume
      29,212
      1.92 Day's Range 2.01
      1.66 52 Week Range 6.80
      Market Cap
      106.192M
      Previous Close
      2.01
      Open
      2.01
      Last Trade
      12
      @
      1.92
      Last Trade Time
      10:45:00
      Financial Volume
      $ 57,254
      VWAP
      1.9599
      Average Volume (3m)
      297,987
      Shares Outstanding
      55,024,470
      Dividend Yield
      -
      PE Ratio
      -0.87
      Earnings Per Share (EPS)
      -2.21
      Revenue
      -
      Net Profit
      -121.83M

      About Prelude Therapeutics Inc

      Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need. Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.preludetx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Prelude Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PRLD. The last closing price for Prelude Therapeutics was $2.01. Over the last year, Prelude Therapeutics shares have traded in a share price range of $ 1.66 to $ 6.80.

      Prelude Therapeutics currently has 55,024,470 shares outstanding. The market capitalization of Prelude Therapeutics is $110.60 million. Prelude Therapeutics has a price to earnings ratio (PE ratio) of -0.87.

      Ask ADVFN Intelligence (AI)

      PRLD Latest News

      More News

      FeaturedSMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains

      4 hours ago

      Prelude Therapeutics’ SMARCA2 Degrader PRT3789 Demonstrated Promising Initial Clinical Activity and Safety Profile in Phase 1 Trial

      -  Encouraging signs of anti-tumor activity including objective responses observed in patients with SMARCA4-mutated non-small cell lung cancer (NSCLC) and esophageal cancer in early PRT3789...

      September 13 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      September 09 2024
      Edgar (US Regulatory)

      Prelude Therapeutics Announces Publication of Abstract for Presentation at the European Society of Medical Oncology (ESMO) Congress 2024

      PRT3789, a novel, highly-selective SMARCA2 degrader in patients with advanced solid tumors with a SMARCA4 mutation oral session presentation: September 13, 2024, 4:00 PM CEST (10:00 AM EST...

      September 09 2024
      GlobeNewswire Inc.

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      August 12 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      August 12 2024
      Edgar (US Regulatory)

      Prelude Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

      Interim Phase 1 data for its first-in-class, highly selective IV SMARCA2 degrader, PRT3789, selected for an oral presentation at the European Society for Medical Oncology (ESMO) Congress 2024 in...

      August 12 2024
      GlobeNewswire Inc.

      Prelude Therapeutics Announces Clinical Collaboration with Merck to Evaluate PRT3789 in Combination with KEYTRUDA® (pembrolizumab) in Patients with SMARCA4-Mutated Cancers

      Combining a first-in-class, highly selective SMARCA2 degrader with an anti-PD-1 therapy may potentially enhance the anti-tumor activity of either agent because of the complementary nature of the...

      July 09 2024
      GlobeNewswire Inc.

      Form 4 - Statement of changes in beneficial ownership of securities

      July 08 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      June 18 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.1901-8.966981132082.122.251.91896752.09691476CS
      4-3.3001-63.09942638625.235.531.94792982.98708521CS
      12-1.7801-47.98113207553.716.81.92979874.09887344CS
      26-2.5901-57.30309734514.526.81.91632974.08218941CS
      52-0.8501-30.57913669062.786.81.661530813.65218877CS
      156-29.6301-93.884980988631.5632.771.661786668.01385585CS
      260-23.8301-92.508152173925.7695.3751.6619124119.03740668CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ELABElevai Labs Inc
      $ 0.136
      (59.62%)
      		345.36M
      EVGOEVgo Inc
      $ 5.51
      (40.20%)
      		32.04M
      RZLVRezolve AI Ltd
      $ 8.9199
      (30.79%)
      		2.7M
      PEGYPineapple Energy Inc
      $ 0.1489
      (29.59%)
      		128.49M
      VRCAVerrica Parmaceuticals Inc
      $ 1.39
      (25.23%)
      		5.12M
      CETXCemtrex Inc
      $ 2.74
      (-47.63%)
      		2.07M
      INVInnventure Inc
       10.71
      (-28.65%)
      		171.37k
      AREBAmerican Rebel Holdings Inc
      $ 2.88
      (-26.72%)
      		452.5k
      WINTWindtree Therapeutics Inc
      $ 1.09
      (-24.31%)
      		1.04M
      SNGXSoligenix Inc
      $ 3.97
      (-18.48%)
      		225.8k
      ELABElevai Labs Inc
      $ 0.136
      (59.62%)
      		390.03M
      PEGYPineapple Energy Inc
      $ 0.1489
      (29.59%)
      		136.21M
      NVDANVIDIA Corporation
      $ 122.83
      (3.35%)
      		111.14M
      MLGOMicroAlgo Inc
      $ 0.3872
      (24.90%)
      		100.13M
      SQQQProShares UltraPro Short QQQ
      $ 7.6701
      (0.00%)
      		58.15M

      PRLD Discussion

      View Posts
      TrendTrade2016 TrendTrade2016 3 months ago
      PRLD...ON ITS WAY TO TARGET
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      PRLD TO 7.74
      👍️0
      Monksdream Monksdream 6 months ago
      PRLD under $5
      👍️0
      Termite7 Termite7 3 years ago
      YES!!!!! .....GET 'EM!!!!!!!
      👍️0

      Your Recent History

      NASDAQ
      PRLD
      Prelude Therapeutics
      Delayed Upgrade Clock